StockData
Axogen, Inc. logo

Axogen, Inc. (AXGN) stock

AXGNNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/30142% above fair value
$56.95+1.58 (+2.85%)

Close on Nov 18, 2026Market cap $3.40BP/E –Yield –

Axogen market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Axogen's market cap was $3.15B on Nov 11, 2026, against $1.32B a year earlier. Over the last 5 years it ranged from $161.60M to $3.15B, with a median of $481.18M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$3.15B+108.4%
2025Dec 31, 2025$1.51B+108.2%
2024Dec 31, 2024$725.16M+146.7%
2023Dec 29, 2023$293.96M-30.3%
2022Dec 30, 2022$421.88M+8.3%
2021Dec 31, 2021$389.41M-45.8%
2020Dec 31, 2020$718.22M+1.7%
2019Dec 31, 2019$705.96M-10.6%
2018Dec 31, 2018$790.07M-16.4%
2017Dec 29, 2017$945.04M+247.6%
2016Dec 30, 2016$271.88M+82.2%
2015Dec 31, 2015$149.22M+138.0%
2014Dec 31, 2014$62.70M-19.5%
2013Dec 31, 2013$77.85M+160.7%
2012Dec 31, 2012$29.87M+1.0%
2011Dec 30, 2011$29.56M–

More Axogen figures

See a number that looks wrong?